Aziyo Biologics, Inc. is a regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on cardiovascular, orthopedic and other applications. The company is headquartered in Cary, North Carolina, and has operations in Silver Spring, Maryland, and Dayton, New Jersey. Aziyo Biologics was founded in 2015 and went public in 2021.